Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236300 · ClinicalTrials.gov registry record · NA
In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01236300 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 66 participants.
The verdict
NCT01236300, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Assess the safety and efficacy of the Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system in differentiating benign from malignant and premalignant cysts (e.g. mucinous from non-mucinous cysts)
Interventions
- DEVICE Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01236300
The ClinicalTrials.gov registry entry for NCT01236300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system is the first listed.
NCT01236300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01236300 about?
NCT01236300 is a clinical study titled "In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors". Assess the safety and efficacy of the Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system in differentiating benign from malignant and premalignant cysts (e.g. mucinous from non-mucinous cysts)
What is the current status of trial NCT01236300?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01236300?
The interventions under investigation include: Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system (DEVICE).
Who is sponsoring clinical trial NCT01236300?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.